Moffitt logo
calledFromCancerPage=False - substr=
testProtocol=

Clinical Trials Search

Search Results:

Order By: 

Showing of 50

CLINICAL TRIAL 18989

A Phase 1b/2 Study of PV-10 Intralesional Injection in Combination with Systemic Immune Checkpoint Inhibition for Treatment of Metastatic Melanoma

Disease Site: Melanoma, skin

View Trial Details

CLINICAL TRIAL 19327

A Phase 2 Trial of Pembrolizumab Plus Bevacizumab in Patients with Metastatic Melanoma or Non-small Cell Lung Cancer with Untreated Brain Metastases

Disease Site: Brain and Nervous System, Lung, Melanoma, skin, Melanoma, Non small cell lung cancer

View Trial Details

CLINICAL TRIAL 19407

An Open-Label, Randomized, Controlled Multi-Center Study of The Efficacy of Daromun (L19IL2 + L19TNF) Neoadjuvant Intratumoral Treatment Followed by Surgery Versus Surgery Alone in Clinical Stage IIIB/C Melanoma Patients

Disease Site: Melanoma, skin

View Trial Details

CLINICAL TRIAL 19441

Pilot Study of Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma

Disease Site: Melanoma, skin

View Trial Details

CLINICAL TRIAL 19475

Phase 1 Study of Trametinib + Ceritinib in Patients with Unresectable Melanoma

Disease Site: Melanoma, skin

View Trial Details

CLINICAL TRIAL 19480

The Reveal Study: A Phase 1/2, Open-Label, Multicenter, Dose Escalation And Dose Expansion Study Of Nktr-262 In Combination With Bempegaldesleukin (Nktr-214) And In combination With Bempegaldesleukin (Nktr-214) Plus Nivolumab In Patients With Locally Advanced Or Metastatic Solid Tumor Malignancies

Disease Site: Any Site, Bones and Joints, Breast, Colon, Corpus Uteri, Eye and Orbit, Lung, Melanoma, Skin - Do Not Use, Ovary, Soft Tissue, Urinary Bladder

View Trial Details

CLINICAL TRIAL 19754

A Phase 3, Randomized, Open-label Study of NKTR-214 Combined with Nivolumab Versus Nivolumab in Participants with Previously Untreated Unresectable or Metastatic Melanoma

Disease Site: Melanoma, skin

View Trial Details

CLINICAL TRIAL 19958

Phase I/II Study of Dabrafenib, Trametinib, and Navitoclax in BRAF Mutant Melanoma (Phase I and II) and Other Solid Tumors (Phase I only)

Disease Site: Bones and Joints, Melanoma, skin

View Trial Details

CLINICAL TRIAL 20162

Phase 1 Trial of Intralesional Immunotherapy with IFx-Hu2.0 Vaccine in Patients with Advanced Merkel Cell Carcinoma or Cutaneous Squamous Cell Carcinoma

Disease Site: Melanoma, skin, Other Skin, Merkel cell carcinoma (neuroendocrine skin cancer), Skin, Squamous Cell Carcinoma (SCC)

View Trial Details

CLINICAL TRIAL 20313

Neoadjuvant Immunotherapy with Intratumoral Tavokinogene Telseplasmid (Tavo) plus Electroporation in Combination with Intravenous Nivolumab in Patients with Operable Locally- Regionally Advanced Melanoma

Disease Site: Melanoma, skin, Melanoma

View Trial Details

CLINICAL TRIAL 20494

A Phase II Study of High Dose Bolus IL2 in Combination with Low Dose Ipilimumab Followed Sequentially by Nivolumab in Patients with Inoperable Stage III or Stage IV Melanoma Who Have Failed Prior Anti-PD1 Immunotherapy

Disease Site: Melanoma, skin

View Trial Details

CLINICAL TRIAL 20557

A Phase II, Open-Label, Multicenter, Randomized Study of Efficacy and Safety of RO7198457 in Combination with Pembrolizumab versus Pembrolizumab in Patients with Previously Untreated Advanced Melanoma

Disease Site: Melanoma, Melanoma, skin

View Trial Details

CLINICAL TRIAL 20641

A Randomized Pilot Trial of Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib and Binimetinib in Advanced Melanoma

Disease Site: Melanoma, skin

View Trial Details

CLINICAL TRIAL 20904

A Randomized Phase 2 Trial of Encorafenib + Binimetinib + Nivolumab vs Ipilimumab + Nivolumab in Braf-V600 Mutant Melanoma with Brain Metastases

Disease Site: Melanoma, skin

View Trial Details

CLINICAL TRIAL 21061

An Examination of Patient Reported Outcomes and Predictors Among Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors

Disease Site: Melanoma, skin

View Trial Details

CLINICAL TRIAL 19733

Motivating a Spectrum of Cancer Patients to Quit Smoking: Intervention Development and Feasibility

Disease Site: Rectum, Other Female Genital, Urinary Bladder, Breast, Colon, Melanoma, skin, Bladder, Breast Cancer, Colorectal, Melanoma, Ovarian, Uterus, Vaginal, Vulva

View Trial Details
;